NCT04187612

Brief Summary

Obstructive Sleep apnea (OSA) is a common and underdiagnosed condition in obese pregnant women with serious and life-threatening complications to the mother and baby. The investiators propose that a non-invasive method may be used to detect patients at risk of OSA, giving these women access to the necessary treatment to treat this condition. The method is a estimation of body water, which has been shown to be linked to OSA in the non-pregnant population. Body water is estimated by applying surface electrodes to a participant who is lying down by measuring bioimpedance through body tissues by applying a tiny current between the electrodes. The electrical stimulation is not felt by the participant and has no negative effects on mother or baby.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 26, 2019

Completed
6 days until next milestone

Study Start

First participant enrolled

December 2, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

December 5, 2019

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

February 26, 2025

Status Verified

February 1, 2025

Enrollment Period

6 years

First QC Date

November 26, 2019

Last Update Submit

February 24, 2025

Conditions

Keywords

pregnancy

Outcome Measures

Primary Outcomes (1)

  • Presence of sleep apnea

    The diagnosis of sleep apnea will be made using apnea hypopnea index (AHI). A diagnosis of OSA is present if a person has an AHI ≥5/hour.

    12 hours

Secondary Outcomes (10)

  • Total body water measurement

    Following consent, this measurement will be done, and will take approximately 30 minutes

  • Mallampati score

    Done during initial exam following consent, this exam will take 1-2 minutes

  • Thyromental distance (cm)

    Done during initial exam following consent, this exam will take 1-2 minutes

  • Subluxation of mandible beyond maxilla

    Done during initial exam following consent, this exam will take 1-2 minutes

  • Neck extension

    Done during initial exam following consent, this exam will take 1-2 minutes

  • +5 more secondary outcomes

Study Arms (1)

Total body water measurement

Total body water will be measured using Bioelectrical Impedance Analysis (BIA).

Device: Bioelectrical Impedance Analysis (BIA)

Interventions

BIA will be used to determine total body water

Total body water measurement

Eligibility Criteria

Age16 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Eligible participants will be approached for consent at our high risk maternal and infant program clinic on the day of their regularly scheduled appointment.

You may qualify if:

  • Participants who give written informed consent
  • Pregnant women in the third trimester of pregnancy
  • Grade III obesity
  • Patients who have prior diagnosis of OSA within the last one year, and non-compliant to treatment such as continuous positive airway pressure (CPAP), or dental appliance
  • Patients suspected to have OSA based on screening questionnaire (see page 2, OSA-Diagnostic tools for further details)

You may not qualify if:

  • Fluid overload states including renal disease, liver disease and congestive heart failure
  • Prior history of vascular surgery in the lower limbs such as varicose vein surgery, vascular by-pass surgery or evidence of venous efficiency.
  • Patients with metal implants in lower limbs or spine, due to possible interference with the leg impedance signals. 58
  • Participants with diagnosed OSA treated with Continuous Positive Airway Pressure (CPAP).
  • Patients requiring urgent sleep physician referral (within four weeks) due to serious medical conditions or safety critical-occupations according to the 2011 Canadian Thoracic Society (CTS) guideline 59 e.g. unstable ischemic heart disease, recent cerebrovascular disease.
  • Implantable cardiac devices

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mount Sinai Hospital

Toronto, Ontario, M5G1X5, Canada

Location

MeSH Terms

Conditions

Sleep Apnea, ObstructiveObesity

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Mrinalini Balki, MD

    MOUNT SINAI HOSPITAL

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 26, 2019

First Posted

December 5, 2019

Study Start

December 2, 2019

Primary Completion

December 1, 2025

Study Completion

December 1, 2025

Last Updated

February 26, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations